Centro Gaucho Integrado | Porto Alegre, Brazil

Research site

(Unclaimed)

Location

R. Grao Para, 160, Porto Alegre, Rio Grande do Sul, Brazil

Site insights

Top conditions

Top treatments

Dexamethasone

Gemcitabine

Vincristine

Odronextamab

Etoposide

Prednisone

Ifosfamide

Doxorubicin

Cisplatin

Prednisolone

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 5 total trials

A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors

The main goals of this clinical trial are to find out what the best dose of the study drug, OTP-01, is for patients with solid tumors through underst...

Enrolling

Advanced Solid Tumors

Drug: OTP-01

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma (OLYMPIA-3)

This study is researching an experimental drug called odronextamab, referred to as study drug, when used in combination with chemotherapy. The study...

Enrolling

Diffuse Large B-cell Lymphoma (DLBCL)

Drug: Cyclophosphamide

Drug: Odronextamab

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma (OLYMPIA-5)

This study is researching an experimental drug called odronextamab (referred to as study drug), in combination with lenalidomide. The study is focuse...

Enrolling

Relapsed/Refractory Follicular Lymphoma

Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL)

Drug: Lenalidomide

Drug: Odronextamab

A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma (OLYMPIA-4)

This study is researching an experimental drug called odronextamab, referred to as study drug. The study is focused on patients with previously treat...

Active, not recruiting

B-Cell Non-Hodgkin Lymphoma (B-NHL)

Drug: Dexamethasone

Drug: Ifosfamide

A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma (LINKER-MM3)

This study is researching an experimental drug called linvoseltamab, also called REGN5458.Linvoseltamab has previously been studied by itself (withou...

Enrolling

Relapsed Refractory Multiple Myeloma (RRMM)

Drug: Pomalidomide

Drug: Elotuzumab

Trial sponsors

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms